Historie von Umsatz, Gewinn und Cashflow aus den offiziellen Geschäftsberichten.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company home care cleaning and disinfecting products and laundry additives, skin sanitization and cleaning products, professional cleaning and disinfecting products, and professional food service products under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Formula 409, Purell, GOJO, CloroxPro, Clorox Healthcare, Hidden Valley, Poett, Clorinda, and Chux brands.
Interaktive Charts und vollständige Abschlüsse ansehen → Bewertungsmodell (DCF) →
| Gewinn- und Verlustrechnung | TTM → 2026-06-30 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 | 2011-06-30 | 2010-06-30 | 2009-06-30 | 2008-06-30 | 2007-06-30 | 2006-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gesamtumsatz | $6.7B | $6.7B | $7.1B | $7.1B | $7.4B | $7.1B | $7.3B | $6.7B | $6.2B | $6.1B | $6.0B | $5.8B | $5.7B | $5.5B | $5.5B | $5.5B | $5.2B | $5.2B | $5.5B | $5.3B | $4.8B | $4.6B |
| Bruttoergebnis | $2.8B | $2.8B | $3.2B | $3.0B | $2.9B | $2.5B | $3.2B | $3.1B | $2.7B | $2.7B | $2.7B | $2.6B | $2.5B | $2.4B | $2.4B | $2.3B | $2.3B | $2.3B | $2.3B | $2.2B | $2.1B | $2.0B |
| Bruttomarge % | 42.3% | 42.3% | 45.2% | 43.0% | 39.4% | 35.8% | 43.6% | 45.6% | 43.9% | 43.7% | 44.7% | 45.1% | 43.6% | 42.7% | 43.2% | 42.1% | 43.5% | 44.3% | 43.0% | 41.2% | 43.1% | 42.2% |
| Betriebsergebnis (EBIT) | $886M | $886M | $1.2B | $723M | $823M | $719M | $1.2B | $1.3B | $1.1B | $1.1B | $1.1B | $1.1B | $1.0B | $969M | $964M | $903M | $921M | $973M | $1.0B | $888M | $867M | $779M |
| Operative Marge % | 13.2% | 13.2% | 16.6% | 10.2% | 11.1% | 10.1% | 16.7% | 18.8% | 17.8% | 18.4% | 18.7% | 18.3% | 17.7% | 17.6% | 17.4% | 16.5% | 17.6% | 18.6% | 18.7% | 16.8% | 17.9% | 16.8% |
| Jahresüberschuss | $587M | $587M | $810M | $280M | $149M | $462M | $710M | $939M | $820M | $823M | $701M | $648M | $580M | $558M | $572M | $541M | $557M | $603M | $537M | $461M | $501M | $444M |
| Nettomarge % | 8.7% | 8.7% | 11.4% | 4.0% | 2.0% | 6.5% | 9.7% | 14.0% | 13.2% | 13.4% | 11.7% | 11.2% | 10.3% | 10.1% | 10.3% | 9.9% | 10.7% | 11.5% | 9.8% | 8.7% | 10.3% | 9.6% |
| EBITDA | — | — | $1.4B | $723M | $564M | $937M | $1.2B | $1.5B | $1.3B | $1.3B | $1.3B | $1.2B | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | $1.2B | $1.1B | $1.1B | $967M |
| Ergebnis je Aktie (EPS) | — | $4.81 | $6.52 | $2.24 | $1.20 | $3.73 | $5.58 | $7.35 | $6.32 | $6.25 | $5.33 | $4.92 | $4.37 | $4.24 | $4.30 | $4.08 | $4.03 | $4.26 | $3.81 | $3.25 | $3.25 | $2.90 |
| Ausstehende Aktien (Mio.) | — | — | 124M | 125M | 124M | 124M | 127M | 128M | 130M | 132M | 132M | 132M | 133M | 132M | 133M | 133M | 138M | 142M | 141M | 142M | 154M | 153M |
Quelle: veröffentlichte Unternehmensberichte (SEC). Bitte prüfen Sie die Zahlen vor Verwendung auf SEC EDGAR.
Bilanzen, Cashflow-Rechnungen, Quartalsdaten und alle Kennzahlen finden Sie im interaktiven Viewer für CLX. /companies/us/CLX
Die Informationen auf dieser Website dienen ausschließlich Bildungs- und Informationszwecken und stellen keine Anlageberatung dar. Es werden keine Kursziele und keine Anlageurteile veröffentlicht.
About TickerBase · Data methodology & sources · Privacy · Terms